Sensus Healthcare, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
SRTS$3.30+3.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
| Common Stock · Additional Paid-In · Treasury Stock · Retained | |||||||
|---|---|---|---|---|---|---|---|
| (in thousands, except shares) | Shares | Amount | Capital | Shares | Amount | Earnings | Total |
| December 31, 2023 | 16,907,095 | $169 | $45,405 | (532,924) | $(3,519) | $6,787 | $48,842 |
| Stock-based compensation | 20,000 | — | 92 | — | — | — | 92 |
| Forfeiture of restricted stock units | (1,500) | — | (1) | — | — | — | (1) |
| Net income | — | — | — | — | — | 2,274 | 2,274 |
| March 31, 2024 | 16,925,595 | $169 | $45,496 | (532,924) | $(3,519) | $9,061 | $51,207 |
| Stock-based compensation | — | — | 66 | — | — | — | 66 |
| Exercise of stock options | 3,000 | — | 17 | — | — | — | 17 |
| Forfeiture of restricted stock units | (750) | — | (1) | — | — | — | (1) |
| Net income | — | — | — | — | — | 1,612 | 1,612 |
| June 30, 2024 | 16,927,845 | $169 | $45,578 | (532,924) | $(3,519) | $10,673 | $52,901 |
| Stock-based compensation | — | — | 45 | — | — | — | 45 |
| Surrender of shares for tax withholding on stock-based compensation | — | — | — | (7,870) | (47) | — | (47) |
| Exercise of stock options | 3,000 | — | 17 | — | — | — | 17 |
| Net income | — | — | — | — | — | 1,215 | 1,215 |
| September 30, 2024 | 16,930,845 | $169 | $45,640 | (540,794) | $(3,566) | $11,888 | $54,131 |
| December 31, 2024 | 17,036,845 | $169 | $45,795 | (541,449) | $(3,571) | $13,434 | $55,827 |
| Stock-based compensation | — | — | 79 | — | — | — | 79 |
| Stock repurchase | — | — | — | (50,360) | (300) | — | (300) |
| Net loss | — | — | — | — | — | (2,572) | (2,572) |
| March 31, 2025 | 17,036,845 | $169 | $45,874 | (591,809) | $(3,871) | $10,862 | $53,034 |
| Stock-based compensation | — | — | 72 | — | — | — | 72 |
| Forfeiture of restricted stock units | (5,000) | — | (5) | — | — | — | (5) |
| Net loss | — | — | — | — | — | (1,037) | (1,037) |
| June 30, 2025 | 17,031,845 | $169 | $45,941 | (591,809) | $(3,871) | $9,825 | $52,064 |
| Stock-based compensation | — | — | 73 | — | — | — | 73 |
| Net loss | — | — | — | — | — | (943) | (943) |
| September 30, 2025 | 17,031,845 | $169 | $46,014 | (591,809) | $(3,871) | $8,882 | $51,194 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.